Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2011

Open Access 01.12.2011 | Case report

Lymphoma of the breast: A mimic of inflammatory breast cancer

verfasst von: Nirupama Anne, Ratnakishore Pallapothu

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2011

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Unusual presentation of breast lymphoma with signs and symptoms suggestive of inflammatory breast cancer.

Discussion

Lymphoma of the breast is uncommon whether it is primary or secondary. Most breast lymphomas are of B cell origin. The most frequent mode of presentation is a painless breast mass. The clinical presentation of localized left breast erythema and edema with an associated left breast mass is common for an inflammatory breast cancer but highly unusual for lymphoma of the breast.

Conclusion

In patients with a left breast mass associated with erythema and edema, the differential diagnosis should include breast lymphoma in addition.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-9-125) contains supplementary material, which is available to authorized users.

Competing interests

Nirupama Anne: Abstract Selection Committee Member for the American Society of Breast Disease; Regional Speaker for Myriad Genetics Laboratory. No conflict of interest is present with this case report. Ratnakishore Pallapothu: None.

Authors' contributions

NA: Literature review, collection of case report, writing, and editing the manuscript. RP: Literature review, writing, and editing the manuscript. Both authors read and approved the final manuscript.

Background

Lymphoma of the breast is uncommon and it constitutes 0.04% to 0.5% of malignant breast neoplasms [1]. Treatment can include surgery, chemotherapy, and radiation. We report a patient who presented with physical exam mimicking an inflammatory breast cancer however had secondary involvement of the breast by regional lymphoma. The clinical presentation was highly unusual which made the diagnosis a challenge.

Case Presentation

The patient is an 89 year old Caucasian lady, with multiple medical co-morbidities, who presented to the Emergency Department with decreased functional ability and a history of left breast erythema and edema over one week duration. On exam there was a left breast mass at 12:00, central lesion surrounding the areola, 3 cm × 3 cm, hard, non-tender and with indistinct borders. There was extensive erythema and edema encompassing the upper outer quadrant of the left breast extending into the axilla (Figure 1). The left axilla had palpable, matted lymph nodes, with a superficial 1.5 cm protruding node. Right breast was within normal limits. Examination of the right axilla and supra-clavicular regions revealed fullness. No other cervical or inguinal lymphadenopathy and no organomegaly was noted on abdominal exam.
Initial laboratory work up showed a normal white blood count of 4,500 with normal differential. A CAT scan of the chest was done which revealed diffuse left breast edema with two large left breast lesions, the largest measuring 7.8 × 7.2 cm in size, (Figure 2) and left axillary adenopathy. It also showed adenopathy involving the right axilla and right supra-clavicular regions. CAT scans of the brain, abdomen and pelvis were normal. She was admitted to the medicine service and treated with intravenous antibiotics based on clinical evidence of left breast erythema/cellulitis.
Breast surgery consultation was obtained. Upon further questioning, the patient admitted to noticing a left axillary mass six months ago, however did not seek any medical attention. She denied constitutional symptoms including fever, chills, night sweats and weight loss. The patient's last mammogram was ten years ago. The patient also has history of dementia.
The differential diagnosis included lymphoma of the breast as well as inflammatory breast cancer. A diagnostic ultrasound of the left breast was then performed. Ultrasound revealed an ill-defined, retro-areolar, hypoechoic, heterogeneous lesion corresponding to the mass on physical exam and to the larger mass seen on the CAT scan of the chest (Figure 3). The patient subsequently underwent an ultrasound guided left breast core biopsy. Pathology was consistent with diffuse large B cell lymphoma (Figures 4 and 5). She underwent further care with the oncology team.

Discussion

Lymphoma of the breast is rare either as a primary or a secondary neoplasm. Most breast lymphomas are of B cell origin. The most common histological subtype is a diffuse large B cell lymphoma [2].
In the present case, the patient's initial presentation was with a left axillary mass followed by the left breast erythema and edema and admission to the hospital. On imaging, the tumor was limited to the left breast, left axilla, right axilla, and right supra-clavicular regions, not involving lymphatic chains in other basin. The lymphoma most likely originated in the left axillary lymph node and then involved the left breast as evidenced by the left breast mass on exam and CAT scan findings. Hence we hypothesize that this is a secondary involvement of the breast since there is involvement of the contra-lateral (right) axilla and supra-clavicular regions as well.
Recent literature shows that the incidence of primary lymphoma of the breast might be increasing [3, 4]. Primary lymphoma of the breast is defined as the tumor localized to the breast with or without ipsilateral axillary lymph node metastases. In 50% of cases of primary lymphoma, the ipsilateral axillary lymph nodes are involved [5, 6].
The presentation of this patient with left breast mass, erythema and edema (Figure 1) is unusual and it does complicate the clinical diagnosis. Most common symptom of breast lymphoma is a painless breast mass, most frequently in the upper outer quadrants [5]. Skin retraction, erythema, peau d' orange appearance, and nipple discharge are uncommon in lymphomas [16].
Distinct mammographic or sonographic features have not been described in the literature for breast lymphoma to differentiate it from breast carcinoma or benign breast entities. Imaging with an ultrasound in the present case did not aid in the differential diagnosis of this lesion. The CAT scan of the chest in this case showed lymph node enlargement on the right (contralateral) side which was the key in considering lymphoma in the differential diagnosis of the left breast mass accompanied with erythema and edema which was clinically mimicking inflammatory breast cancer.
The definitive diagnosis should be made with a core biopsy and will allow for therapeutic planning. At present, the treatment of breast lymphoma, whether primary or secondary, should be with systemic chemotherapy [7, 8]. The role of surgery is minimal since the tumors are highly sensitive both to chemotherapy and radiation therapy [911]. Ryan et al reported statistically significant poor cause-specific survival for patients who underwent mastectomy [12]. Local radiotherapy to involved sites is used to prevent loco-regional recurrence [1012]. This delivery of radiation therapy alone has been found by Ryan et al to improve overall survival [12]. Kim et al reported that a short course of chemotherapy followed by local radiation therapy was a safe approach for stage IAE disease [11]. For stage IIAE disease, combination of full course of chemotherapy and local radiation therapy has to be considered [11, 12]. Survival outcomes were studied in the International Lymphoma Study Group and statistically significant benefit was shown resulting from the addition of radiation therapy to systemic chemotherapy [12].
The Extra Nodal Lymphoma Study Group also did note that young age and stage IIE disease were associated with poor prognosis [12]. Prognosis of patients with breast lymphoma can range from 26 and 66% for 5 year survival rates [1318]. Diffuse large B cell type has worse prognosis than other histologic subtypes and has significant risk of contralateral breast involvement [1318]. For secondary lymphoma involving the breast, the prognosis is dependent on the staging of the primary [1318].

Conclusions

Lymphoma of the breast is a very rare entity. This case highlights the atypical presentation of lymphoma mimicking an inflammatory breast cancer. Core biopsy of the breast lesion will aid in resolving the diagnostic dilemma and tailor the subsequent management.
Written informed consent was obtained from the patient's daughter, health care proxy, for publication of this case report and accompanying images since the patient lacked capacity due to dementia. A copy of the written informed consent is available for review by the Editor-in-Chief of this journal.

Acknowledgements

We thank, Dr. Michael Zur, Department of Pathology at Our Lady of Lourdes Memorial Hospital in Binghamton NY, for providing the slides of the diffuse large B cell lymphoma.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

Nirupama Anne: Abstract Selection Committee Member for the American Society of Breast Disease; Regional Speaker for Myriad Genetics Laboratory. No conflict of interest is present with this case report. Ratnakishore Pallapothu: None.

Authors' contributions

NA: Literature review, collection of case report, writing, and editing the manuscript. RP: Literature review, writing, and editing the manuscript. Both authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Takemura A, Mizukami Y, Takayama T, Taniya T, Okumura H: Primary malignant lymphoma of the breast. Jpn J Radiol. 2009, 27: 221-4. 10.1007/s11604-009-0324-5.CrossRefPubMed Takemura A, Mizukami Y, Takayama T, Taniya T, Okumura H: Primary malignant lymphoma of the breast. Jpn J Radiol. 2009, 27: 221-4. 10.1007/s11604-009-0324-5.CrossRefPubMed
2.
Zurück zum Zitat Khalbuss W, Villas B, Bakhshandeh M: Cytomorphology and immunophenotyping of Burkitt's lymphoma presenting as a breast mass. Breast J. 2006, 12: 177-8. 10.1111/j.1075-122X.2006.00230.x.CrossRefPubMed Khalbuss W, Villas B, Bakhshandeh M: Cytomorphology and immunophenotyping of Burkitt's lymphoma presenting as a breast mass. Breast J. 2006, 12: 177-8. 10.1111/j.1075-122X.2006.00230.x.CrossRefPubMed
3.
Zurück zum Zitat Dixon JM, Lumsden AB, Krajewski A, Elton RA, Anderson TJ: Primary lymphoma of the breast. Br J Surg. 1987, 74: 214-7. 10.1002/bjs.1800740322.CrossRefPubMed Dixon JM, Lumsden AB, Krajewski A, Elton RA, Anderson TJ: Primary lymphoma of the breast. Br J Surg. 1987, 74: 214-7. 10.1002/bjs.1800740322.CrossRefPubMed
4.
Zurück zum Zitat Brustein S, Filippa DA, Kimmel M, Lieberman PH, Rosen PP: Malignant lymphoma of the breast: A study of 53 patients. Ann Surg. 1987, 205: 144-50. 10.1097/00000658-198702000-00008.PubMedCentralCrossRefPubMed Brustein S, Filippa DA, Kimmel M, Lieberman PH, Rosen PP: Malignant lymphoma of the breast: A study of 53 patients. Ann Surg. 1987, 205: 144-50. 10.1097/00000658-198702000-00008.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Garg NK, Bagul NB, Rubin G, Shah EF: Primary lymphoma of the breast involving both axillae and bilateral breast carcinoma. World J of Surg Onc. 2008, 6: 52-10.1186/1477-7819-6-52.CrossRef Garg NK, Bagul NB, Rubin G, Shah EF: Primary lymphoma of the breast involving both axillae and bilateral breast carcinoma. World J of Surg Onc. 2008, 6: 52-10.1186/1477-7819-6-52.CrossRef
6.
Zurück zum Zitat Pinheiro RG, Colleoni GW, Baiocchi OC, Kerbauy FR, Duarte LC, Bordin JO: Primary breast lymphoma: an uncommon but curable disease. Leuk Lymphoma. 2003, 44 (1): 149-51. 10.1080/1042819021000040369.CrossRefPubMed Pinheiro RG, Colleoni GW, Baiocchi OC, Kerbauy FR, Duarte LC, Bordin JO: Primary breast lymphoma: an uncommon but curable disease. Leuk Lymphoma. 2003, 44 (1): 149-51. 10.1080/1042819021000040369.CrossRefPubMed
7.
Zurück zum Zitat Babovic N, Jelic S, Jovanovic V: Primary non-Hodgkin lymphoma of the breast: is it possible to avoid mastectomy?. J Exp Clin Cancer Res. 2000, 19: 149-54.PubMed Babovic N, Jelic S, Jovanovic V: Primary non-Hodgkin lymphoma of the breast: is it possible to avoid mastectomy?. J Exp Clin Cancer Res. 2000, 19: 149-54.PubMed
8.
Zurück zum Zitat Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP: Lymphomas of the breast: primary and secondary involvement. Cancer. 2002, 94 (1): 6-13. 10.1002/cncr.10163.CrossRefPubMed Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP: Lymphomas of the breast: primary and secondary involvement. Cancer. 2002, 94 (1): 6-13. 10.1002/cncr.10163.CrossRefPubMed
9.
Zurück zum Zitat Brogi E, Harris NL: Lymphomas of the breast: Pathology and clinical behavior. Semin Oncol. 1999, 26: 357-64.PubMed Brogi E, Harris NL: Lymphomas of the breast: Pathology and clinical behavior. Semin Oncol. 1999, 26: 357-64.PubMed
10.
Zurück zum Zitat Wakabayaski H, Maeba T, Maeta H: A case of primary malignant lymphoma of the bilateral breast. A study of surgical treatment based on the clinicopathological evaluation of its local involvement and postoperative recurrence site. Jpn J Breast Cancer. 1999, 9: 675-80. Wakabayaski H, Maeba T, Maeta H: A case of primary malignant lymphoma of the bilateral breast. A study of surgical treatment based on the clinicopathological evaluation of its local involvement and postoperative recurrence site. Jpn J Breast Cancer. 1999, 9: 675-80.
11.
Zurück zum Zitat Kim SH, Ezekiel MP, Kim RY: Primary lymphoma of the breast. Am J Clin Oncol. 1999, 22: 381-83. 10.1097/00000421-199908000-00011.CrossRefPubMed Kim SH, Ezekiel MP, Kim RY: Primary lymphoma of the breast. Am J Clin Oncol. 1999, 22: 381-83. 10.1097/00000421-199908000-00011.CrossRefPubMed
12.
Zurück zum Zitat Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, Roos D, Lennard A, Devizzi L, Crabb S, Hossfeld D, Pratt G, Dell'Olio M, Choo SP, Bociek RG, Radford J, Lade S, Gianni AM, Zucca E, Cavalli F, Seymour JF: Primary diffuse large B cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extra Nodal Lymphoma Study group. Ann Oncol. 2009, 19 (2): 233-41.CrossRef Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, Roos D, Lennard A, Devizzi L, Crabb S, Hossfeld D, Pratt G, Dell'Olio M, Choo SP, Bociek RG, Radford J, Lade S, Gianni AM, Zucca E, Cavalli F, Seymour JF: Primary diffuse large B cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extra Nodal Lymphoma Study group. Ann Oncol. 2009, 19 (2): 233-41.CrossRef
13.
Zurück zum Zitat Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, Calabrese L, Pruneri G, Santoro L, Kuper-Hommel M, Tsang R, Zinzani PL, Taghian A, Zucca E, Cavalli F: Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic features and outcome: A study by the International Extra Nodal Lymphoma Study Group. Ann Oncol. 2009, 20 (12): 1993-9. 10.1093/annonc/mdp238.CrossRefPubMed Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, Calabrese L, Pruneri G, Santoro L, Kuper-Hommel M, Tsang R, Zinzani PL, Taghian A, Zucca E, Cavalli F: Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic features and outcome: A study by the International Extra Nodal Lymphoma Study Group. Ann Oncol. 2009, 20 (12): 1993-9. 10.1093/annonc/mdp238.CrossRefPubMed
14.
Zurück zum Zitat Giardini R, Piccolo C, Rilke F: Primary non-Hodgkin's lymphomas of the female breast. Cancer. 1992, 69: 725-35. 10.1002/1097-0142(19920201)69:3<725::AID-CNCR2820690320>3.0.CO;2-C.CrossRefPubMed Giardini R, Piccolo C, Rilke F: Primary non-Hodgkin's lymphomas of the female breast. Cancer. 1992, 69: 725-35. 10.1002/1097-0142(19920201)69:3<725::AID-CNCR2820690320>3.0.CO;2-C.CrossRefPubMed
15.
Zurück zum Zitat Abbondanzo SL, Seidman JD, Lefkowitz M, Tavassoli FA, Krishnan J: Primary diffuse large B-cell lymphoma of the breast. A clinicopathological study of 31 cases. Pathol Res Pract. 1996, 192 (1): 37-43.CrossRefPubMed Abbondanzo SL, Seidman JD, Lefkowitz M, Tavassoli FA, Krishnan J: Primary diffuse large B-cell lymphoma of the breast. A clinicopathological study of 31 cases. Pathol Res Pract. 1996, 192 (1): 37-43.CrossRefPubMed
16.
Zurück zum Zitat Kuper Hommel MJ, Snijder S, Janssen-Heijnen ML, Vrints LW, Kluin-Nelemans JC, Coebergh JW, Noordijk EM, Vreugdenhil G: Treatment and survival of 38 breast lymphomas: a population based study with clinical and pathological reviews. Ann Hematol. 2003, 82 (7): 397-404. 10.1007/s00277-003-0664-7.CrossRefPubMed Kuper Hommel MJ, Snijder S, Janssen-Heijnen ML, Vrints LW, Kluin-Nelemans JC, Coebergh JW, Noordijk EM, Vreugdenhil G: Treatment and survival of 38 breast lymphomas: a population based study with clinical and pathological reviews. Ann Hematol. 2003, 82 (7): 397-404. 10.1007/s00277-003-0664-7.CrossRefPubMed
17.
Zurück zum Zitat Gholam D, Bibeau F, Weshi El, Bosq J, Ribrag V: Primary breast lymphoma. Leuk Lymphoma. 2003, 44 (7): 1173-8. 10.1080/1042819031000079195.CrossRefPubMed Gholam D, Bibeau F, Weshi El, Bosq J, Ribrag V: Primary breast lymphoma. Leuk Lymphoma. 2003, 44 (7): 1173-8. 10.1080/1042819031000079195.CrossRefPubMed
18.
Zurück zum Zitat Liu MT, Hsieh CY, Wang AY, Pi CP, Chang TH, Huang CC, Huang CY: Primary breast lymphoma: a pooled analysis of prognostic factors and survival 93 cases. Ann Saudi Med. 2005, 25 (4): 288-93.PubMed Liu MT, Hsieh CY, Wang AY, Pi CP, Chang TH, Huang CC, Huang CY: Primary breast lymphoma: a pooled analysis of prognostic factors and survival 93 cases. Ann Saudi Med. 2005, 25 (4): 288-93.PubMed
Metadaten
Titel
Lymphoma of the breast: A mimic of inflammatory breast cancer
verfasst von
Nirupama Anne
Ratnakishore Pallapothu
Publikationsdatum
01.12.2011
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2011
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-9-125

Weitere Artikel der Ausgabe 1/2011

World Journal of Surgical Oncology 1/2011 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.